Jinling Pharmaceutical Company Limited

¥6.36As of Sun 8 Nov 2026, 12:00 UTC
SZSE:000919Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (6.17%)
Div yield 1.57%
ROE 0.90%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.28
PE TTM 89.05
TSR TTM (9.59%)
Mkt cap ¥3.955B
ROIC 0.86%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥7.93
24.62%
(86.52%)
Hold 12|10|2|8|11
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.09
0.09
0.09
0.09
12.43%
11.35%
10.22%
1.98%
Revenue¥M
421.4
415.4
414.4
403.1
9.34%
1.90%
(2.42%)
(2.27%)
Peers (US$592.9M)
Cap (US$)
PE
595.9M
32.54x
Capital
TTM
5Y
10Y
Leveragex
1.452
0.165
0.143
EBIT/Intx
0.686
0.066
0.060
Own earn%
2.20
(11.84)
(17.92)
Sh yield%
39.20
14.24
14.31
Owners
Insiders/Inst%
4.83
60.45
Short interest%
1.41
SBC / revenue%
1.10
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
0–5
$1 testx
—
Incr. ROIC%
5